0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month FREE

[+] Author Affiliations

Section Editor: Walter W. Tunnessen, MD

More Author Information
Arch Pediatr Adolesc Med. 1998;152(4):406. doi:.
Text Size: A A A
Published online

Figure 1. The axilla appears hyperpigmented and velvety, characteristic of acanthosis nigricans.

Figure 2. The face is acromegaloid and the neck shows changes of acanthosis nigricans.

Figure 3. The muscles are prominent and the abdomen is distended secondary to hepatomegaly.

Generalized lipodystrophy, also known as lipoatrophic diabetes, is a progressive multisystem disorder characterized by the loss of subcutaneous and other body fat. The congenital form of generalized lipodystrophy, known as the Lawrence-Seip syndrome, has its onset in the first 2 years of life and is inherited in an autosomal recessive fashion.1 A sporadic, acquired generalized form has its onset in the first to third decades of life. Partial acquired lipodystrophy occurs sporadically and is characterized by the loss of fat in localized areas.

Individuals affected with the generalized form of lipodystrophy develop a cadaveric appearance with acromegalic face and prominent muscles, the result of accelerated growth and the loss of subcutaneous fat. A complete loss of body fat does not occur in generalized lipodystrophy. There seems to be preservation of fat in sites where fat serves a mechanical function.2 Large blood vessels beneath the skin may appear prominent because of the loss of fat. Other features of the disorder are hepatomegaly, acanthosis nigricans, genital hypertrophy, and hirsutism. Metabolic abnormalities include insulin resistance with the eventual development of nonketotic, hyperinsulinemic diabetes mellitus, an increased basal metabolic rate, and hyperlipidemia leading to generalized atherosclerosis with coronary artery disease and fatty infiltration of the liver, eventually leading to cirrhosis and portal hypertension.

Acanthosis nigricans invariably develops in affected individuals as a symmetric dermatosis with a hyperpigmented, velvety appearance that gives a sandpaper-like sensation on palpation. The sites of predilection of acanthosis nigricans include the neck, groin, axillae, and inframammary areas. Affected areas over the knees, elbows, and knuckles have a pebbly feel, more common in the acquired form of the disease. Acanthosis nigricans is associated with other disorders that include obesity, endocrinopathies, autoimmune metabolic diseases, and malignant neoplasms, many of which also feature insulin resistance.3

Hyperinsulinism, a hallmark of lipodystrophy, is due to heterogeneous defects in insulin binding, receptor expression, receptor kinase function, or postreceptor signaling. There is resistance to ketone production secondary to a paucity of stored fat and elevated circulating insulin levels.3 The presence of hypothalamic releasing factors in the serum of some patients with lipodystrophy suggests a lack of hypothalamic regulation.4 The acromegaloid appearance of these patients suggests elevated growth hormone secretion, but their circulating levels of growth hormone and insulin growth factor-1 may be normal, high, or low.5,6 The bone age is usually advanced. Thyroid and adrenal function are generally normal. Plasma glucagon levels range from normal to markedly elevated.7

The treatment of generalized lipodystrophy is supportive. Caloric restriction may improve hyperlipidemia and carbohydrate tolerance. Good control of blood glucose levels is very difficult to achieve because of the underlying insulin resistance. In one report, the selective dopaminergic blocking agent, pimozide, reversed the physical abnormalities as well as the biochemical disturbances.4

Accepted for publication August 15, 1997.

Reprints: Naji A. Kulaylat, MD, Saudi Aramco-Al-Hasa Health Center, Box 6030, Saudi Aramco, Mubarraz 31311, Saudi Arabia.

Janaki  VRPremalatha  SRao  NR  et al.  Lawrence-Seip syndrome. Br J Dermatol. 1980;103693- 696
Link to Article
Garg  AFleckenstein  JLPeshock  RMGrundy  SM Peculiar distribution of adipose tissue in patients with congenital lipodystrophy. J Clin Endocrinol Metab. 1992;75353- 361
Moller  DEFlier  JS Insulin resistance mechanisms, syndromes and implications. N Engl J Med. 1991;325938- 948
Link to Article
Corbin  AUpton  GVMabry  CCHollingsworth  DR Diencephalic involvement in generalized lipodystrophy. Acta Endocrinol. 1974;77209- 220
Flier  JSYoung  JBLandsberg  L Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps. N Engl J Med. 1980;303970- 973
Link to Article
Tzagournis  MGeorge  JHerrold  J Increased growth hormone in partial and total lipodystrophy. Diabetes. 1973;22388- 396
Rossini  AASelf  JAoki  TT  et al.  Metabolic and endocrine studies in a case of lipoatrophic diabetes. Metabolism. 1977;26637- 650
Link to Article

Tables

References

Janaki  VRPremalatha  SRao  NR  et al.  Lawrence-Seip syndrome. Br J Dermatol. 1980;103693- 696
Link to Article
Garg  AFleckenstein  JLPeshock  RMGrundy  SM Peculiar distribution of adipose tissue in patients with congenital lipodystrophy. J Clin Endocrinol Metab. 1992;75353- 361
Moller  DEFlier  JS Insulin resistance mechanisms, syndromes and implications. N Engl J Med. 1991;325938- 948
Link to Article
Corbin  AUpton  GVMabry  CCHollingsworth  DR Diencephalic involvement in generalized lipodystrophy. Acta Endocrinol. 1974;77209- 220
Flier  JSYoung  JBLandsberg  L Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps. N Engl J Med. 1980;303970- 973
Link to Article
Tzagournis  MGeorge  JHerrold  J Increased growth hormone in partial and total lipodystrophy. Diabetes. 1973;22388- 396
Rossini  AASelf  JAoki  TT  et al.  Metabolic and endocrine studies in a case of lipoatrophic diabetes. Metabolism. 1977;26637- 650
Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles